Navigation Links
Magnetic resonance angiography in clinical medicine

Cardiovascular, eurovascular and other vascular diseases are the leading causes of death. Imaging of blood vessels thus important in depiction of stenotic, occlusive, aneurismal, inflammatory or vascular malformations.Conventional x-ray angiography and digital subtraction angiography (DSA) are used to depict vascular lesions with high accuracy via intravascular administration of contrast (dye) material.// It is the gold standard with a very high spatial resolution and temporal resolution with the possibility of multiple projections.

DSA is useful to detect several abnormalities such as arteriosclerosis, and arteriovenous occlusion or stenosis, cerebral aneurysms, and A.V.malformations.It is an x-ray-imaging test, which takes pictures of the blood vessels or arteries of the body. However, it requires arterial catheterisation, injection of contrast, and exposure to ionising radiation with their associated risks.

Another method, doppler ultrasonography (US), though non-invasive and sensitive to flow, suffers from significant attenuation in bone, air and bowel gas, thereby limiting the regions in which it can be successfully applied. With the invention of non-invasie magnetic resonance imaging (MRI) technique, imaging of flow has blossomed into a powerful technique to visualise blood flow in vessel, called MR Angiography (MRA).

Blood vessels are rendered, not in the usual tomographic format of standard MR images, but as a projection over a large volume, similar to a conventional angiogram.It does not require the injection of an external contrast because MRA uses the natural magnetic properties of the hydrogen atoms present in our bodies to create (with the help of a computer) images of the blood vesels.

It is a special type of MRI study and often, the patient having a MRI scan can have MRA study as well at the same time. Whereas MRI looks at the organs and soft tissues of the human body, MRA looks specifically at the blood ve ssels. It enables the determination of flow velocity, direction, and even profiles within the vessel. It is painles and the study takes 30 to 60 minutes, whereas DSA sometimes takes several hours.

MRA is recommended for patients suspected to have narrowing or other abnormalities of arteries or veins in head, neck cardiovascular or in other parts of the body. MRA can also detect abnormal widening of the vessels called aneurysms of the arteries or veins. There are no known risks of MRA examination. Patients with heart pacemakers, brain aneurysm clips, inner ear implants or any other metal implants cannot have in MRA examination.

In summary, it is an excellent method of choice to evaluate the thoracic aorta, pulmonary arteires, abdominal aorta and its branches (renal and mesenteric arteries).MRA is also useful in patients for who surgery is anticipated and these conditions include, tumors, aneurysms, vascular malformations, and vascular occlusions or thromboses.

Furthermore, the combination of MRI and MRA within a single examination procedure will frequently avoid the need for multiple diagnostic imaging methods, such as DSA, CT, and US. Finally, the well-known advantages of MRA over other imaging methods, such as avoidance of ionising radiations, the lack of need for dye/contrast gents, and the wide field of view, may influence the spectrum of indications such that the focus is particularly on patients for whom these risk factors should be avoided.


Related medicine news :

1. Magnetic Stimulation Found Effective for Parkinson’
2. Magnetic Stimulation For Parkinson’s Diseas
3. Strong Magnetic Stimulation Can Help Treating Severe Depression
4. Magnetic Resonance Spectrometry for speedy diagnosis of Brain disorders
5. Magnetic Resonance Imaging Can Now Be Used For Mind Reading
6. Repetitive Magnetic Stimulation of the Brain Gives the Stroke Patients a Reprieve
7. Keep Kids Away from Magnetic Toys
8. Massive Recall of Magnetic Toys in US
9. Nuclear magnetic resonance spectroscopy aids in mapping protein structure
10. Three Teslas magnetic resonance imager acquired. Shot in the arm for research
11. How do patients benefit of clinical trials
Post Your Comments:

(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: